Dekorationsartikel gehören nicht zum Leistungsumfang.
Sprache:
Englisch
102,95 €*
Versandkostenfrei per Post / DHL
Lieferzeit 1-2 Wochen
Kategorien:
Beschreibung
Now in paperback, this text covers the dramatic developments that have occurred in basic neuroscience and clinical research in cognitive neurology and dementia. The text is based on the clinical approach to the patient, and provides essential knowledge that is fundamental to clinical practice.
Now in paperback, this text covers the dramatic developments that have occurred in basic neuroscience and clinical research in cognitive neurology and dementia. The text is based on the clinical approach to the patient, and provides essential knowledge that is fundamental to clinical practice.
Über den Autor
Masud Husain is Professor of Neurology & Cognitive Neuroscience at the Nuffield Department of Clinical Neurosciences, University of Oxford, UK. He read Physiological Sciences/Medicine (1981-84) at Oxford before completing his PhD in 1987. He held a Harkness Fellowship and was a postdoctoral fellow at MIT, prior to returning to Oxford to finish his clinical degree. After Neurology training in London, he held a joint appointment as Consultant Neurologist and Wellcome Trust Senior Fellow (2000-12). In 2013, he was awarded a Principal Fellowship by The Wellcome Trust and moved to Oxford where he is a Professorial Fellow at New College. Previously he was Professor of Clinical Neurology at UCL & The National Hospital for Neurology & Neurosurgery, London and Deputy Director of the UCL Institute of Cognitive Neuroscience.
Jonathan M. Schott is Professor of Neurology, at the Dementia Research Centre, Department of Neurodegenerative Diseases, UCL Institute of Neurology, UK. He was awarded a First Class BSc in Basic Medical Sciences with Physiology (Imperial College, 1993), gained Honours (in surgery) at medical finals, and was awarded the Malcolm Morris Memorial Prize (1996). Jonathan joined the Dementia Research Centre (DRC), Institute of Neurology (2001-5), where he was awarded his MD (UCL, 2004), for investigation of the role of serial magnetic resonance imaging as a tool for tracking the progressions of Alzheimer's disease (AD) and in aiding diagnosis. After completing his clinical training, he rejoined the DRC as HEFCE/NHS Senior Lecturer/Honorary Consultant at the Institute of Neurology, UCL (2009 - ).
Jonathan M. Schott is Professor of Neurology, at the Dementia Research Centre, Department of Neurodegenerative Diseases, UCL Institute of Neurology, UK. He was awarded a First Class BSc in Basic Medical Sciences with Physiology (Imperial College, 1993), gained Honours (in surgery) at medical finals, and was awarded the Malcolm Morris Memorial Prize (1996). Jonathan joined the Dementia Research Centre (DRC), Institute of Neurology (2001-5), where he was awarded his MD (UCL, 2004), for investigation of the role of serial magnetic resonance imaging as a tool for tracking the progressions of Alzheimer's disease (AD) and in aiding diagnosis. After completing his clinical training, he rejoined the DRC as HEFCE/NHS Senior Lecturer/Honorary Consultant at the Institute of Neurology, UCL (2009 - ).
Inhaltsverzeichnis
- Section 1: Normal cognitive function
- 1: Charles Gross: Historical aspects of neurology
- 2: Giovanna Zamboni: Functional specialisation and network connectivity in brain function
- 3: Teresa Torralva, Ezequiel Gleichgerrcht, Agustin Ibañez, and Facundo Manes: The frontal lobes
- 4: Morgan D. Barense, Jason D. Warren, Timothy J. Bussey, and Lisa M. Saksida: The temporal lobes
- 5: Masud Husain: Parietal cortex
- 6: Geraint Rees: The human occipital lobe
- 7: James Rowe and Timothy Rittman: The basal ganglia in cognitive disorders
- 8: Marco Catani: Principles of white matter organization
- 9: Trevor W. Robbins: Neurochemistry of cognition
- Section 2: Cognitive dysfunction
- 10: Seyed A Sajjadi and Peter J. Nestor: Bedside assessment of cognition
- 11: Diana Caine and Sebastian Crutch: Neuropsychological assessment
- 12: Dalia Abou Zeky and Argye E. Hillis: Acquired disorders of language and speech
- 13: Lara Harris, Kate Humphreys, Ellen M. Migo, and Michael D. Kopelman: Memory disorders
- 14: Anna Katharina Schaadt and Georg Kerkhoff: Vision and visual processing deficits
- 15: Paolo Bartolomeo and Raffaella Migliaccio: Disorders of attentional processes
- 16: Georg Goldenberg: Apraxia
- 17: Marinella Cappelletti: The neuropsychology of acquired calculation disorders
- 18: Alexander P. Leff: Disorders of reading and writing
- 19: Dylan Wint and Jeffrey Cummings: Neuropsychiatric aspects of cognitive impairment
- Section 3: Cognitive impairment and dementia
- 20: Thais Minett and Carol Brayne: Epidemiology of dementias
- 21: Jonathan M. Schott, Nick C. Fox, and Martin N. Rossor: Assessment and investigation of the cognitively impaired adult
- 22: Barbara C. van Munster, Sophia de Rooij, and Sharon K. Inouye: Delirium, drugs, toxins
- 23: Sam Nightingale, Benedict Daniel Michael, and Tom Solomon: CNS infections
- 24: Nicholas J. C. Smith and Timothy M. Cox: Metabolic dementia
- 25: Geert Jan Biessels and Philip Scheltens: Vascular cognitive impairment
- 26: Sergi Martinez-Ramirez, Steven M. Greenberg, and Anand Viswanathan: Cerebral amyloid angiopathy and CNS vasculitis
- 27: Maria A. Ron: CNS inflammatory causes: Multiple sclerosis
- 28: Sarosh R. Irani, Thomas D. Miller, and Angela Vincent: CNS inflammatory causes: Autoimmune encephalitis
- 29: Tamas Revesz, Tammaryn Lashley, and Janice L. Holton: Pathology of degenerative dementias
- 30: Rita Guerreiro and Jose Bras: Genetics of degenerative dementias
- 31: Davina J. Hensman Moss, Nicholas W. Wood, and Sarah J. Tabrizi: Other genetic causes of cognitive impairment
- 32: Bruno Dubois and Olga Uspenskaya: Changing concepts and new definitions for Alzheimer's disease
- 33: Susan Rountree and Rachelle S. Doody: Presentation and Management of Alzheimer's disease
- 34: Jonathan D. Rohrer and Jason D. Warren: Primary progressive aphasia
- 35: Bruce Miller and Soo Jin Yoon: Frontotemporal dementia
- 36: Hasmet A. Hanagasi, Basar Bilgiç, and Murat Emre: Dementia with lewy bodies and Parkinson's disease dementia
- 37: Elizabeth A. Coon and Keith A. Josephs: Corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy, argyrophilic grain disease and rarer neurodegenerative diseases
- 38: Simon Mead, Peter Rudge, and John Collinge: Prion diseases
- 39: David J. Sharp, Simon Fleminger, and Jane Powell: Traumatic brain injury (TBI)
- 40: Tom Foltynie and Ludvic Zrinzo: Neurosurgery for cognitive disorders
- 41: Philip D. Harvey: Cognition in severe mental illness: Schizophrenia, bipolar disorder and depression
- Section 1: Normal cognitive function
- 1: Charles Gross: Historical aspects of neurology
- 2: Giovanna Zamboni: Functional specialisation and network connectivity in brain function
- 3: Teresa Torralva, Ezequiel Gleichgerrcht, Agustin Ibañez, and Facundo Manes: The frontal lobes
- 4: Morgan D. Barense, Jason D. Warren, Timothy J. Bussey, and Lisa M. Saksida: The temporal lobes
- 5: Masud Husain: Parietal cortex
- 6: Geraint Rees: The human occipital lobe
- 7: James Rowe and Timothy Rittman: The basal ganglia in cognitive disorders
- 8: Marco Catani: Principles of white matter organization
- 9: Trevor W. Robbins: Neurochemistry of cognition
- Section 2: Cognitive dysfunction
- 10: Seyed A Sajjadi and Peter J. Nestor: Bedside assessment of cognition
- 11: Diana Caine and Sebastian Crutch: Neuropsychological assessment
- 12: Dalia Abou Zeky and Argye E. Hillis: Acquired disorders of language and speech
- 13: Lara Harris, Kate Humphreys, Ellen M. Migo, and Michael D. Kopelman: Memory disorders
- 14: Anna Katharina Schaadt and Georg Kerkhoff: Vision and visual processing deficits
- 15: Paolo Bartolomeo and Raffaella Migliaccio: Disorders of attentional processes
- 16: Georg Goldenberg: Apraxia
- 17: Marinella Cappelletti: The neuropsychology of acquired calculation disorders
- 18: Alexander P. Leff: Disorders of reading and writing
- 19: Dylan Wint and Jeffrey Cummings: Neuropsychiatric aspects of cognitive impairment
- Section 3: Cognitive impairment and dementia
- 20: Thais Minett and Carol Brayne: Epidemiology of dementias
- 21: Jonathan M. Schott, Nick C. Fox, and Martin N. Rossor: Assessment and investigation of the cognitively impaired adult
- 22: Barbara C. van Munster, Sophia de Rooij, and Sharon K. Inouye: Delirium, drugs, toxins
- 23: Sam Nightingale, Benedict Daniel Michael, and Tom Solomon: CNS infections
- 24: Nicholas J. C. Smith and Timothy M. Cox: Metabolic dementia
- 25: Geert Jan Biessels and Philip Scheltens: Vascular cognitive impairment
- 26: Sergi Martinez-Ramirez, Steven M. Greenberg, and Anand Viswanathan: Cerebral amyloid angiopathy and CNS vasculitis
- 27: Maria A. Ron: CNS inflammatory causes: Multiple sclerosis
- 28: Sarosh R. Irani, Thomas D. Miller, and Angela Vincent: CNS inflammatory causes: Autoimmune encephalitis
- 29: Tamas Revesz, Tammaryn Lashley, and Janice L. Holton: Pathology of degenerative dementias
- 30: Rita Guerreiro and Jose Bras: Genetics of degenerative dementias
- 31: Davina J. Hensman Moss, Nicholas W. Wood, and Sarah J. Tabrizi: Other genetic causes of cognitive impairment
- 32: Bruno Dubois and Olga Uspenskaya: Changing concepts and new definitions for Alzheimer's disease
- 33: Susan Rountree and Rachelle S. Doody: Presentation and Management of Alzheimer's disease
- 34: Jonathan D. Rohrer and Jason D. Warren: Primary progressive aphasia
- 35: Bruce Miller and Soo Jin Yoon: Frontotemporal dementia
- 36: Hasmet A. Hanagasi, Basar Bilgiç, and Murat Emre: Dementia with lewy bodies and Parkinson's disease dementia
- 37: Elizabeth A. Coon and Keith A. Josephs: Corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy, argyrophilic grain disease and rarer neurodegenerative diseases
- 38: Simon Mead, Peter Rudge, and John Collinge: Prion diseases
- 39: David J. Sharp, Simon Fleminger, and Jane Powell: Traumatic brain injury (TBI)
- 40: Tom Foltynie and Ludvic Zrinzo: Neurosurgery for cognitive disorders
- 41: Philip D. Harvey: Cognition in severe mental illness: Schizophrenia, bipolar disorder and depression
Details
Erscheinungsjahr: | 2018 |
---|---|
Fachbereich: | Andere Fachgebiete |
Genre: | Importe, Medizin |
Rubrik: | Wissenschaften |
Medium: | Taschenbuch |
Inhalt: | Kartoniert / Broschiert |
ISBN-13: | 9780198831082 |
ISBN-10: | 0198831080 |
Sprache: | Englisch |
Einband: | Kartoniert / Broschiert |
Redaktion: |
Schott, Jonathan M.
Husain, Masud |
Hersteller: | Oxford University Press |
Verantwortliche Person für die EU: | Deutsche Bibelgesellschaft, Postfach:81 03 40, D-70567 Stuttgart, vertrieb@dbg.de |
Maße: | 268 x 216 x 25 mm |
Von/Mit: | Jonathan M. Schott (u. a.) |
Erscheinungsdatum: | 29.10.2018 |
Gewicht: | 1,358 kg |
Über den Autor
Masud Husain is Professor of Neurology & Cognitive Neuroscience at the Nuffield Department of Clinical Neurosciences, University of Oxford, UK. He read Physiological Sciences/Medicine (1981-84) at Oxford before completing his PhD in 1987. He held a Harkness Fellowship and was a postdoctoral fellow at MIT, prior to returning to Oxford to finish his clinical degree. After Neurology training in London, he held a joint appointment as Consultant Neurologist and Wellcome Trust Senior Fellow (2000-12). In 2013, he was awarded a Principal Fellowship by The Wellcome Trust and moved to Oxford where he is a Professorial Fellow at New College. Previously he was Professor of Clinical Neurology at UCL & The National Hospital for Neurology & Neurosurgery, London and Deputy Director of the UCL Institute of Cognitive Neuroscience.
Jonathan M. Schott is Professor of Neurology, at the Dementia Research Centre, Department of Neurodegenerative Diseases, UCL Institute of Neurology, UK. He was awarded a First Class BSc in Basic Medical Sciences with Physiology (Imperial College, 1993), gained Honours (in surgery) at medical finals, and was awarded the Malcolm Morris Memorial Prize (1996). Jonathan joined the Dementia Research Centre (DRC), Institute of Neurology (2001-5), where he was awarded his MD (UCL, 2004), for investigation of the role of serial magnetic resonance imaging as a tool for tracking the progressions of Alzheimer's disease (AD) and in aiding diagnosis. After completing his clinical training, he rejoined the DRC as HEFCE/NHS Senior Lecturer/Honorary Consultant at the Institute of Neurology, UCL (2009 - ).
Jonathan M. Schott is Professor of Neurology, at the Dementia Research Centre, Department of Neurodegenerative Diseases, UCL Institute of Neurology, UK. He was awarded a First Class BSc in Basic Medical Sciences with Physiology (Imperial College, 1993), gained Honours (in surgery) at medical finals, and was awarded the Malcolm Morris Memorial Prize (1996). Jonathan joined the Dementia Research Centre (DRC), Institute of Neurology (2001-5), where he was awarded his MD (UCL, 2004), for investigation of the role of serial magnetic resonance imaging as a tool for tracking the progressions of Alzheimer's disease (AD) and in aiding diagnosis. After completing his clinical training, he rejoined the DRC as HEFCE/NHS Senior Lecturer/Honorary Consultant at the Institute of Neurology, UCL (2009 - ).
Inhaltsverzeichnis
- Section 1: Normal cognitive function
- 1: Charles Gross: Historical aspects of neurology
- 2: Giovanna Zamboni: Functional specialisation and network connectivity in brain function
- 3: Teresa Torralva, Ezequiel Gleichgerrcht, Agustin Ibañez, and Facundo Manes: The frontal lobes
- 4: Morgan D. Barense, Jason D. Warren, Timothy J. Bussey, and Lisa M. Saksida: The temporal lobes
- 5: Masud Husain: Parietal cortex
- 6: Geraint Rees: The human occipital lobe
- 7: James Rowe and Timothy Rittman: The basal ganglia in cognitive disorders
- 8: Marco Catani: Principles of white matter organization
- 9: Trevor W. Robbins: Neurochemistry of cognition
- Section 2: Cognitive dysfunction
- 10: Seyed A Sajjadi and Peter J. Nestor: Bedside assessment of cognition
- 11: Diana Caine and Sebastian Crutch: Neuropsychological assessment
- 12: Dalia Abou Zeky and Argye E. Hillis: Acquired disorders of language and speech
- 13: Lara Harris, Kate Humphreys, Ellen M. Migo, and Michael D. Kopelman: Memory disorders
- 14: Anna Katharina Schaadt and Georg Kerkhoff: Vision and visual processing deficits
- 15: Paolo Bartolomeo and Raffaella Migliaccio: Disorders of attentional processes
- 16: Georg Goldenberg: Apraxia
- 17: Marinella Cappelletti: The neuropsychology of acquired calculation disorders
- 18: Alexander P. Leff: Disorders of reading and writing
- 19: Dylan Wint and Jeffrey Cummings: Neuropsychiatric aspects of cognitive impairment
- Section 3: Cognitive impairment and dementia
- 20: Thais Minett and Carol Brayne: Epidemiology of dementias
- 21: Jonathan M. Schott, Nick C. Fox, and Martin N. Rossor: Assessment and investigation of the cognitively impaired adult
- 22: Barbara C. van Munster, Sophia de Rooij, and Sharon K. Inouye: Delirium, drugs, toxins
- 23: Sam Nightingale, Benedict Daniel Michael, and Tom Solomon: CNS infections
- 24: Nicholas J. C. Smith and Timothy M. Cox: Metabolic dementia
- 25: Geert Jan Biessels and Philip Scheltens: Vascular cognitive impairment
- 26: Sergi Martinez-Ramirez, Steven M. Greenberg, and Anand Viswanathan: Cerebral amyloid angiopathy and CNS vasculitis
- 27: Maria A. Ron: CNS inflammatory causes: Multiple sclerosis
- 28: Sarosh R. Irani, Thomas D. Miller, and Angela Vincent: CNS inflammatory causes: Autoimmune encephalitis
- 29: Tamas Revesz, Tammaryn Lashley, and Janice L. Holton: Pathology of degenerative dementias
- 30: Rita Guerreiro and Jose Bras: Genetics of degenerative dementias
- 31: Davina J. Hensman Moss, Nicholas W. Wood, and Sarah J. Tabrizi: Other genetic causes of cognitive impairment
- 32: Bruno Dubois and Olga Uspenskaya: Changing concepts and new definitions for Alzheimer's disease
- 33: Susan Rountree and Rachelle S. Doody: Presentation and Management of Alzheimer's disease
- 34: Jonathan D. Rohrer and Jason D. Warren: Primary progressive aphasia
- 35: Bruce Miller and Soo Jin Yoon: Frontotemporal dementia
- 36: Hasmet A. Hanagasi, Basar Bilgiç, and Murat Emre: Dementia with lewy bodies and Parkinson's disease dementia
- 37: Elizabeth A. Coon and Keith A. Josephs: Corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy, argyrophilic grain disease and rarer neurodegenerative diseases
- 38: Simon Mead, Peter Rudge, and John Collinge: Prion diseases
- 39: David J. Sharp, Simon Fleminger, and Jane Powell: Traumatic brain injury (TBI)
- 40: Tom Foltynie and Ludvic Zrinzo: Neurosurgery for cognitive disorders
- 41: Philip D. Harvey: Cognition in severe mental illness: Schizophrenia, bipolar disorder and depression
- Section 1: Normal cognitive function
- 1: Charles Gross: Historical aspects of neurology
- 2: Giovanna Zamboni: Functional specialisation and network connectivity in brain function
- 3: Teresa Torralva, Ezequiel Gleichgerrcht, Agustin Ibañez, and Facundo Manes: The frontal lobes
- 4: Morgan D. Barense, Jason D. Warren, Timothy J. Bussey, and Lisa M. Saksida: The temporal lobes
- 5: Masud Husain: Parietal cortex
- 6: Geraint Rees: The human occipital lobe
- 7: James Rowe and Timothy Rittman: The basal ganglia in cognitive disorders
- 8: Marco Catani: Principles of white matter organization
- 9: Trevor W. Robbins: Neurochemistry of cognition
- Section 2: Cognitive dysfunction
- 10: Seyed A Sajjadi and Peter J. Nestor: Bedside assessment of cognition
- 11: Diana Caine and Sebastian Crutch: Neuropsychological assessment
- 12: Dalia Abou Zeky and Argye E. Hillis: Acquired disorders of language and speech
- 13: Lara Harris, Kate Humphreys, Ellen M. Migo, and Michael D. Kopelman: Memory disorders
- 14: Anna Katharina Schaadt and Georg Kerkhoff: Vision and visual processing deficits
- 15: Paolo Bartolomeo and Raffaella Migliaccio: Disorders of attentional processes
- 16: Georg Goldenberg: Apraxia
- 17: Marinella Cappelletti: The neuropsychology of acquired calculation disorders
- 18: Alexander P. Leff: Disorders of reading and writing
- 19: Dylan Wint and Jeffrey Cummings: Neuropsychiatric aspects of cognitive impairment
- Section 3: Cognitive impairment and dementia
- 20: Thais Minett and Carol Brayne: Epidemiology of dementias
- 21: Jonathan M. Schott, Nick C. Fox, and Martin N. Rossor: Assessment and investigation of the cognitively impaired adult
- 22: Barbara C. van Munster, Sophia de Rooij, and Sharon K. Inouye: Delirium, drugs, toxins
- 23: Sam Nightingale, Benedict Daniel Michael, and Tom Solomon: CNS infections
- 24: Nicholas J. C. Smith and Timothy M. Cox: Metabolic dementia
- 25: Geert Jan Biessels and Philip Scheltens: Vascular cognitive impairment
- 26: Sergi Martinez-Ramirez, Steven M. Greenberg, and Anand Viswanathan: Cerebral amyloid angiopathy and CNS vasculitis
- 27: Maria A. Ron: CNS inflammatory causes: Multiple sclerosis
- 28: Sarosh R. Irani, Thomas D. Miller, and Angela Vincent: CNS inflammatory causes: Autoimmune encephalitis
- 29: Tamas Revesz, Tammaryn Lashley, and Janice L. Holton: Pathology of degenerative dementias
- 30: Rita Guerreiro and Jose Bras: Genetics of degenerative dementias
- 31: Davina J. Hensman Moss, Nicholas W. Wood, and Sarah J. Tabrizi: Other genetic causes of cognitive impairment
- 32: Bruno Dubois and Olga Uspenskaya: Changing concepts and new definitions for Alzheimer's disease
- 33: Susan Rountree and Rachelle S. Doody: Presentation and Management of Alzheimer's disease
- 34: Jonathan D. Rohrer and Jason D. Warren: Primary progressive aphasia
- 35: Bruce Miller and Soo Jin Yoon: Frontotemporal dementia
- 36: Hasmet A. Hanagasi, Basar Bilgiç, and Murat Emre: Dementia with lewy bodies and Parkinson's disease dementia
- 37: Elizabeth A. Coon and Keith A. Josephs: Corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy, argyrophilic grain disease and rarer neurodegenerative diseases
- 38: Simon Mead, Peter Rudge, and John Collinge: Prion diseases
- 39: David J. Sharp, Simon Fleminger, and Jane Powell: Traumatic brain injury (TBI)
- 40: Tom Foltynie and Ludvic Zrinzo: Neurosurgery for cognitive disorders
- 41: Philip D. Harvey: Cognition in severe mental illness: Schizophrenia, bipolar disorder and depression
Details
Erscheinungsjahr: | 2018 |
---|---|
Fachbereich: | Andere Fachgebiete |
Genre: | Importe, Medizin |
Rubrik: | Wissenschaften |
Medium: | Taschenbuch |
Inhalt: | Kartoniert / Broschiert |
ISBN-13: | 9780198831082 |
ISBN-10: | 0198831080 |
Sprache: | Englisch |
Einband: | Kartoniert / Broschiert |
Redaktion: |
Schott, Jonathan M.
Husain, Masud |
Hersteller: | Oxford University Press |
Verantwortliche Person für die EU: | Deutsche Bibelgesellschaft, Postfach:81 03 40, D-70567 Stuttgart, vertrieb@dbg.de |
Maße: | 268 x 216 x 25 mm |
Von/Mit: | Jonathan M. Schott (u. a.) |
Erscheinungsdatum: | 29.10.2018 |
Gewicht: | 1,358 kg |
Sicherheitshinweis